Cavalier Funds

Fundamental Growth

FOR INSTITUTIONAL USE ONLY

Cavalier Fundamental Growth Fund - Monthly Commentary - March 2019:

Cavalier’s Fundamental Growth Fund (CAFGX), managed by Louis Navellier, had slightly negative performance in March, down -0.39% MTD, trailing the S&P Global BMI benchmark which was up 1.08% for the month. With equities remaining in a ‘risk on’ environment through March and the Fund’s technology and Industrial stocks were mostly stronger. The Fund’s two main contributors for March were iRadimed Corp. up 12.36% and CyberArk Software Ltd, up 8.45%, both contributing 0.17%. The Fund’s two main detractors were Abiomed Inc. down -14.62%, detracting -0.46% and Boeing Co. down -13.31%, detracting -0.44% from the Fund’s overall performance.

The performance information quoted here represents past performance, which is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. To obtain Fund performance information current to the most recent month-end, please call 1-800-773-3863, or visit www.cavalierfunds.com

ICCAV0419002

An investment in the Cavalier Fundamental Growth Fund is subject to investment risks, including the possible loss of some or the entire principal amount invested. There can be no assurance that the Cavalier Fundamental Growth Fund will be successful in meeting its investment objectives. Investment in the Cavalier Fundamental Growth Fund is also subject to the following risks: Commons Stock Risk, Currency Risk, Cybersecurity Risk, Depository Receipts, Foreign Securities and Emerging Markets Risk, Investment Advisor Risk, Large-Cap Securities Risk, Market Risk, Micro-Cap Securities Risk, Portfolio Turnover Risk, Quantitative Model Risk, and Small-Cap and Mid-Cap Securities Risk. The Cavalier Fundamental Growth Fund may invest in foreign securities and emerging markets, and these investments have risks that differ significantly from those associated with domestic securities. More information about these risks can be found in the Cavalier Fundamental Growth Fund’s prospectus. 

Investors should consider the investment objective, management fees, risks, charges and expenses of the Fund carefully before investing or sending money. The Prospectus contains this and other information about the Fund. For a current Prospectus, call 800-773-3863. Please read the Prospectus carefully before you invest. Current and future holdings are subject to change and risk.  

The Cavalier Funds are distributed by Capital Investment Group, Inc., Member FINRA/SIPC, 100 E. Sic Forks Road, Suite 200, Raleigh, NC 27609, (800) 773-3863. There is no affiliation between Cavalier Investments, the Investment Advisor to the Fund, Navellier & Associates, Inc., the Investment Sub-Advisor to the Fund, including their principals, and Capital Investment Group, Inc.